RevOpsis Therapeutics focuses on combating vision loss by leveraging its innovative bispecific Surrobody platform. This technology enables the development of targeted therapeutic agents for a variety of ocular conditions, offering hope for improved treatments and outcomes in eye care.
National Ranking28372nd
in United States Regional Ranking30989th
in North America Global Ranking74332nd
worldwide Rankings by